Fetal and neonatal alloimmune thrombocytopenia: Harvesting the evidence to develop a Clinical approach to management

American Journal of Perinatology

Volumn 28, Issue 2, 2011, Pages 137-144

  Symington, Amanda ^a   Paes, Bosco ^a,b  

^a MCMASTER CHILDREN S HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

alloimmune thrombocytopenia; fetal; management; Maternal; neonatal

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN;

ARTICLE; BLOOD SAMPLING; CORTICOSTEROID THERAPY; FETUS BLOOD; HUMAN; IMMUNOTHERAPY; INTRAUTERINE BLOOD TRANSFUSION; MEDLINE; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; PRENATAL CARE; PRENATAL SCREENING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTEMIC THERAPY; THROMBOCYTE;

ANTIGENS, HUMAN PLATELET; FEMALE; FETAL THERAPIES; HUMANS; INCIDENCE; INFANT, NEWBORN; PREGNANCY; PRENATAL DIAGNOSIS; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 79551505855     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0030-1263296     Document Type: Article

References (55)

1. Burrows R F., Kelton J G. Fetal thrombocytopenia and its relation to maternal thromboc (Pubitemid 23335892)
2. Metcalfe P, Watkins N A., Ouwehand W H. et al. Nomenclature of human platelet antigens. Vox Sang 2003 85 240-245 (Pubitemid 37247810)
3. Gruel Y, Boizard B, Daffos F, Forestier F, Caen J, Wautier J L. Determination of platelet antigens and glycoproteins in the human fetus. Blood 1986 68 488-492 (Pubitemid 16050673)
4. Blanchette V S., Chen L, de Friedberg Z S., Hogan V A., Trudel E, Décary F. Alloimmunization to the PlA1 platelet antigen: results of a prospective study. Br J Haematol 1990 74 209-215 (Pubitemid 20041097)
5. Doughty H A., Murphy M F., Metcalfe P, Waters A H. Antenatal screening for fetal alloimmune thrombocytopenia: the results of a pilot study. Br J Haematol 1995 90 321-325
6. Durand-Zaleski I, Schlegel N, Blum-Boisgard C, Uzan S, Dreyfus M, Kaplan C, Immune Thrombocytopenia Working Group. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Am J Perinatol 1996 13 423-431 (Pubitemid 26425206)
7. Kjeldsen-Kragh J, Killie M K., Tomter G et al. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 2007 110 833-839 (Pubitemid 47267418)
8. Turner M L., Bessos H, Fagge T et al. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 2005 45 1945-1956 (Pubitemid 43971423)
9. Williamson L M., Hackett G, Rennie J et al. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998 92 2280-2287 (Pubitemid 28452968)
10. Blanchette V S., Johnson J, Rand M. The management of alloimmune neonatal thrombocytopenia. Baillieres Best Pract Res Clin Haematol 2000 13 365-390
11. Rayment R, Brunskill S J., Stanworth S, Soothill P W., Roberts D J., Murphy M F. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database Syst Rev 2005 1 Issue 1 CD004226
12. Mueller-Eckhardt C, Mueller-Eckhardt G, Willen-Ohff H et al. Immunogenicity of and immune response to the human platelet antigen Zwa is strongly associated with HLA-B8 and DR3. Tissue Antigens 1985 26 71-76 (Pubitemid 15059449)
13. Davoren A, McParland P, Crowley J, Barnes A, Kelly G, Murphy W G. Antenatal screening for human platelet antigen-1a: results of a prospective study at a large maternity hospital in Ireland. BJOG 2003 110 492-496 (Pubitemid 36556132)
14. Maslanka K, Guz K, Zupanska B. Antenatal screening of unselected pregnant women for HPA-1a antigen, antibody and alloimmune thrombocytopenia. Vox Sang 2003 85 326-327 (Pubitemid 37522608)
15. Dreyfus M, Kaplan C, Verdy E, Schlegel N, Durand-Zaleski I, Tchernia G, Immune Thrombocytopenia Working Group. Frequency of immune thrombocytopenia in newborns: a prospective study. Blood 1997 89 4402-4406 (Pubitemid 27260250)
16. de Moerloose P, Boehlen F, Extermann P, Hohfeld P. Neonatal thrombocytopenia: incidence and characterization of maternal antiplatelet antibodies by MAIPA assay. Br J Haematol 1998 100 735-740 (Pubitemid 28126108)
17. Uhrynowska M, Niznikowska-Marks M, Zupaska B. Neonatal and maternal thrombocytopenia: incidence and immune background. Eur J Haematol 2000 64 42-46 (Pubitemid 30055542)
18. Ghevaert C, Campbell K, Walton J et al. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia. Transfusion 2007 47 901-910 (Pubitemid 46669006)
19. Bussel J B., Zabusky M R., Berkowitz R L., McFarland J G. Fetal alloimmune thrombocytopenia. N Engl J Med 1997 337 22-26 (Pubitemid 27290843)
20. Spencer J A., Burrows R F. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001 41 45-55 (Pubitemid 32201293)
21. Killie M K., Husebekk A, Kjeldsen-Kragh J, Skogen B. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica 2008 93 870-877 (Pubitemid 351821723)
22. Skogen B, Husebekk A, Killie M K., Kjeldsen-Kragh J. Neonatal alloimmune thrombocytopenia is not what it was: a lesson learned from a large prospective screening and intervention program. Scand J Immunol 2009 70 531-534
23. Radder C M., Brand A, Kanhai H HH. Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it? Vox Sang 2003 84 318-325 (Pubitemid 36702338)
24. Kanhai H HH, Porcelijn L, Engelfriet C P. et al. Management of alloimmune thrombocytopenia. Vox Sang 2007 93 370-385 (Pubitemid 350135084)
25. Kjeldsen-Kragh J, Husebekk A, Killie M K., Skogen B. Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme? Transfus Apher Sci 2008 38 183-188
26. Fretheim A. Cost-effectiveness analysis of screening for neonatal alloimmune thrombocytopenia was based on invalid assumption. BJOG 2008 115 412-413 author reply 413-414, discussion 414
27. Killie M K., Kjeldsen-Kragh J, Husebekk A, Skogen B, Olsen J A., Kristiansen I S. Cost-effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia. BJOG 2007 114 588-595 (Pubitemid 46587959)
28. Kiefel V, Santoso S, Weisheit M, Müeller-Eckhardt C. Monoclonal antibodyspecific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987 70 1722-1726 (Pubitemid 18055614)
29. Arnold D M., Smith J W., Kelton J G. Diagnosis and management of neonatal alloimmune thrombocytopenia. Transfus Med Rev 2008 22 255-267
30. Kaplan C, Daffos F, Forestier F et al. Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets. Blood 1988 72 340-343
31. Overton T G., Duncan K R., Jolly M, Letsky E, Fisk N M. Serial aggressive platelet transfusion for fetal alloimmune thrombocytopenia: platelet dynamics and perinatal outcome. Am J Obstet Gynecol 2002 186 826-831 (Pubitemid 34494371)
32. Daffos F, Forestier F, Muller J Y. et al. Prenatal treatment of alloimmune thrombocytopenia. Lancet 1984 2 632 (Pubitemid 14038731)
33. Nicolini U, Rodeck C H., Kochenour N K. et al. In-utero platelet transfusion for alloimmune thrombocytopenia. Lancet 1988 2 506
34. Birchall J E., Murphy M F., Kaplan C, Kroll H, European Fetomaternal Alloimmune Thrombocytopenia Study Group. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. Br J Haematol 2003 122 275-288 (Pubitemid 36859615)
35. van den Akker E S., Oepkes D, Lopriore E, Brand A, Kanhai H H. Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective. BJOG 2007 114 469-473 (Pubitemid 46393288)
36. Paidas M J., Berkowitz R L., Lynch L et al. Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis. Am J Obstet Gynecol 1995 172 2 Pt 1 475-479
37. Simon H U., Späth P J. IVIGmechanisms of action. Allergy 2003 58 543-552
38. Koleba T, Ensom M HH. Pharmacokinetics of intravenous immunoglobulin: a systematic review. Pharmacotherapy 2006 26 813-827 (Pubitemid 43807633)
39. Bussel J B., Berkowitz R L., Lynch L et al. Antenatal management of alloimmune thrombocytopenia with intravenous -globulin: a randomized trial of the addition of low-dose steroid to intravenous -globulin. Am J Obstet Gynecol 1996 174 1414-1423 (Pubitemid 26165254)
40. Berkowitz R L., Kolb E A., McFarland J G. et al. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstet Gynecol 2006 107 91-96
41. Berkowitz R L., Lesser M L., McFarland J G. et al. Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial. Obstet Gynecol 2007 110 2 Pt 1 249-255 (Pubitemid 47356647)
42. van den Akker E, Oepkes D, Brand A, Kanhai H H. Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia? BJOG 2006 113 781-783 (Pubitemid 43961738)
43. Bassler D, Greinacher A, Okascharoen C et al. A systematic review and survey of the management of unexpected neonatal alloimmune thrombocytopenia. Transfusion 2008 48 92-98
44. Ouwehand W H., Smith G, Ranasinghe E. Management of severe alloimmune thrombocytopenia in the newborn. Arch Dis Child Fetal Neonatal Ed 2000 82 F173-F175 (Pubitemid 30313549)
45. Bussel J B., Primiani A. Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates. Blood Rev 2008 22 33-52 (Pubitemid 351193026)
46. Mueller-Eckhardt C, Kiefel V, Grubert A et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989 1 363-366 (Pubitemid 19103082)
47. Kiefel V, Bassler D, Kroll H et al. Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT). Blood 2006 107 3761-3763
48. Win N. Provision of random-donor platelets (HPA-1a positive) in neonatal alloimmune thrombocytopenia due to anti HPA-1a alloantibodies. Vox Sang 1996 71 130-131 (Pubitemid 26288280)
49. Allen D, Verjee S, Rees S, Murphy M F., Roberts D J. Platelet transfusion in neonatal alloimmune thrombocytopenia. Blood 2007 109 388-389 (Pubitemid 46053085)
50. Bakchoul T, Sachs U J., Wittekindt B, Sclösser R, Bein G, Santoso S. Treatment of fetomaternal neonatal alloimmune thrombocytopenia with random platelets. Pediatr Blood Cancer 2008 50 1293-1294 (Pubitemid 351555573)
51. Derycke M, Dreyfus M, Ropert J C., Tchernia G. Intravenous immunoglobulin for neonatal isoimmune thrombocytopenia. Arch Dis Child 1985 60 667-669 (Pubitemid 15006932)
52. Sidiropoulos D, Straume B. The treatment of neonatal isoimmune thrombocytopenia with intravenous immunoglobin (IgG i.v.). Blut 1984 48 383-386 (Pubitemid 14094302)
53. Suarez C R., Anderson C. High-dose intravenous gammaglobulin (IVG) in neonatal immune thrombocytopenia. Am J Hematol 1987 26 247-253 (Pubitemid 18020040)
54. Ballin A, Andrew M, Ling E, Perlman M, Blanchette V. High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia. J Pediatr 1988 112 789-792
55. Linder N, Shapiro S C., Moser A M., Roitman J, Engelhard D. Treatment of neonatal immune thrombocytopenia with high dose intravenous -globulin. Dev Pharmacol Ther 1990 14 205-208 (Pubitemid 20239644)